Skip to content

Marrow Therapeutics Series B: $173M

Public sources — Collected from public sources, not yet cross-checked.

Marrow Therapeutics raised $173 million in a series b round led by Scion Life Sciences and Venbio Partners and OrbiMed, announced Nov. 17.

Facts

Amount
$173 million
Currency
USD
Stage
Series B
Announced
Nov 17, 2026

Investors

Use of funds

Building manufacturing capacity.

As stated by the company.

Sources

  1. 1.Sickle Cell Drug: Marrow Raises $173 Million Without Releasing Anemia or Selectivity Data — techtimes.com, Nov 17, 2026

Public sources — Collected from public sources, not yet cross-checked.Last verified Nov 17, 2026